This website is intended for healthcare professionals in the UK. This promotional Webinar is organised and funded by Teva UK Limited.
Prescribing information and adverse event reporting details can be found at the bottom of the page.

HEAD START from Teva
Head Start - leading education in headache management since 2017
Teva is dedicated to providing valuable education to healthcare professionals across the multi-disciplinary team to optimise the management, treatment and care for headache and migraine patients. The Head Start programme activities are created by healthcare professionals, for healthcare professionals, in a variety of formats to suit busy schedules but also enable networking opportunities.
Head Start is designed for Consultants, Nurses, GPs and other healthcare professionals from the UK with an interest in headache and migraine, and includes a mix of face to face events, live and virtual events.
Our events

Head Start Annual Meeting
Our next meeting will be in 2024. This promotional meeting is organised and funded by Teva UK Limited and open to Consultants, Nurses, GPs, and other healthcare professionals from the UK with an interest in headache and migraine

Webinar: 'Migraine mAbs in Pain Clinics: From Theory to Practical Tips
This promotional meeting is organised and funded by Teva UK Limited and open to Consultants, Nurses, GPs, and other healthcare professionals from the UK with an interest in headache and migraine
Rated highly by previous delegates

of delegates who responded would be interested in attending future Head Start meetings
When asked "Would you be interested in attending future meetings?" 100% of those who responded answered "Yes" (n=32).

of delegates rated the overall meeting in 2022 as "Excellent"
When asked "How would you rate this meeting overall?" 84% of the 45 delegates who responded answered "5 (Excellent)" on the rating scale. [1 being Poor and 5 being Excellent]
This promotional meeting is open to HCPs from the UK with an interest in headache. The Head Start meetings and webinars are organised and funded by Teva UK Limited. |
![]() |
Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX +44 (0) 1977 628500 | www.tevauk.com |
|
AJOVY®▼(fremanezumab) UK Prescribing Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva using the Reporting Side Effects Form or tel: 0207 540 7117 or email: medinfo@tevauk.com. |
|
Privacy Policy | Pharmacovigilance Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events |